Linzagolix (KLH-2109, OBE-2109) is a potent, non-peptide, and orally active GnRH antagonist. Linzagolix can be used for uterine fibroids, endometriosis, adenomyosis research[1][2][3].
Molecular Weight:
508.42
Purity:
99.68
CAS Number:
[935283-04-8]
Formula:
C22H15F3N2O7S
Target:
GnRH Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted